PDS Biotechnology Corporation (NASDAQ: PDSB)
$4.14
-0.0850 ( -2.01% ) 601.9K
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It isĀ engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Market Data
Open
$4.14
Previous close
$4.23
Volume
601.9K
Market cap
$152.04M
Day range
$4.03 - $4.42
52 week range
$2.53 - $6.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 10, 2024 |
8-k | 8K-related | 45 | May 08, 2024 |
3 | Insider transactions | 2 | May 02, 2024 |
8-k | 8K-related | 15 | May 02, 2024 |
4 | Insider transactions | 1 | May 02, 2024 |
def | Proxies and info statements | 5 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
pre | Proxies and info statements | 5 | Apr 18, 2024 |
10-k | Annual reports | 90 | Mar 28, 2024 |
8-k | 8K-related | 33 | Mar 27, 2024 |